Biomarker challenges in the pursuit of personalized neoadjuvant chemotherapy for muscle-invasive bladder cancer: conclusions from SWOG S1314

Transl Androl Urol. 2024 Mar 31;13(3):458-462. doi: 10.21037/tau-23-620. Epub 2024 Mar 12.
No abstract available

Keywords: Bladder neoplasms; CO-eXpression ExtrapolatioN (COXEN); biomarkers; neoadjuvant therapy; tumor.

Publication types

  • Editorial
  • Comment